ASP Isotopes Inc. (ASPI) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$2.13 +4.93% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.14

ASP Isotopes Inc. (ASPI) carries a Roarable Rating of E (Strong Sell) with 21/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E β€’ RED ALERT Cap $326.5M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ASPI Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is ASPI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-02, ASP Isotopes Inc. (NASDAQ: ASPI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 21/100 at a spot price of $2.13 (+4.93% 1D, market cap $326.5M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, ASPI ranks #261 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does ASPI compare to OEC and NL in the Materials sector?
β–Ό

Within the Materials sector (Major Chemicals), ASPI carries a Roarable E (21/100 RQD), trailing P/E of N/A, gross margin of 14.3%, and ROIC of -35.0%. By comparison, OEC (Orion S.A.) holds a D- grade (39/100 RQD, P/E N/A, ROIC 2.2%, cap $313.1M) and NL (NLI Holdings Inc.) posts a D grade (45/100 RQD, P/E N/A, ROIC 3.4%, cap $341.8M). Among the 5-stock peer group, ASPI leads on earnings multiple (N/A) while NL leads on capital efficiency (3.4% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ASPI?
β–Ό

Per ASPI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001921865), ASP Isotopes Inc. generated $23.8M in revenue (+475.5% YoY), -$159.8M in net income, and -$47.4M in free cash flow against $498.0M in total assets and $1.5M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $2.14 (+0.70%)🧬 Dilution Drag (+2.48% YoY Shares)βš™οΈ Cash Engine: 5/20 (E) β€’ 0% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (21/100 Β· E) historically underperformed SPY in 71% of rolling 90-day windows (-11.6% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERRED ALERT β€’ E
025507510021
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E Β· Rk E
Cash (5)Whales (3)SEC (5)Macro (5)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-16.4% Base Target
$11 Bull$2 Base$1 Bear
πŸ“¬ FREE ASPI RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for ASPI)Realized 20D OHLCV Swing Band: Β±12.5%
Deterministic 5-Pillar Attribution (21/100 Composite)
πŸ” WHY ASPI SCORES 21/100 (E) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Cash Engine Quality+5/20 pts (24% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 14.3% Gross Margin

β–² #2 Bullish Driver: SEC 10-K Forensic Risk+5/20 pts (24% of score)

Altman Z-Score 0.72 (DISTRESS RISK (<1.8)) β€’ Piotroski F-Score 4/9

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
29
Grade E$2.44-15.6% Next Q
Q2 (-2Q)
26
Grade E$2.06-1.9% Next Q
Q3 (-1Q)
24
Grade E$2.02+5.4% Next Q
Current
21
Grade E$2.13-11.6% Hist 90D Ξ±
Trajectory: E (29) β†’ E (21)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a ASPI Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While ASPI currently carries a cautious 21/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Materials with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.94) and Max Pain ($2.24) forces dealer call-delta covering toward $11.30.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ASPIβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œASPI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
SEC FORM 4 Γ— 13F HEDGE FUNDS Γ— CONGRESSIONAL STOCK ACT

ASPI Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales β†’
β–² Disclosed Buys: 0 ($0)β–Ό Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (ASPI)

No recent open-market Form 4 cluster sales or emergency dumps flagged on ASPI. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ASPI)

  • βœ“Walkthrough of ASPI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ASPI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -58.72%β–² RESISTANCE BREAKOUT
2026-11-02O $2.03H $2.13L $2.03C $2.13VOL 3.81M
RES: $2.06SUP: $1.43SMA50: $2.94SMA200: $4.83
$9.01$7.08$5.15$3.22$1.29RES $2.06SUP $1.43$2.132026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ASPI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ASPI today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for ASPI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ASPI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ASPI)

1. Head-to-Head Materials Peer Comparison (ASPI vs. OEC, NL, GEVO, SLI)

Industry: Major Chemicals (67 Tracked Issuers)

Across 270 tracked Materials securities in the Roarable RQD universe, ASP Isotopes Inc. (ASPI) ranks #261 by composite RQD confidence (21/100, grade E) and #197 by equity capitalization ($326.5M). Within this direct 5-issuer industry benchmark cohort, ASPI leads on earnings valuation at N/A trailing P/E, while NL leads on capital efficiency and profitability with 3.4% ROIC and 30.4% gross margin. NL currently holds the highest overall quantitative score in the immediate peer group at 45/100 (D) compared with ASPI at 21/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
ASPI ACTIVE
ASP Isotopes Inc.
E 21/100 β€” 14.3% -35.0% +4.93% $326.5M Benchmark Subject
OEC
Orion S.A.
D- 39/100 β€” 19.9% 2.2% +1.28% $313.1M /oec-vs-aspi β†’
NL
NLI Holdings Inc.
D 45/100 β€” 30.4% 3.4% -0.71% $341.8M /nl-vs-aspi β†’
GEVO
Gevo Inc.
E 24/100 β€” β€” -2.9% -0.82% $299.2M /gevo-vs-aspi β†’
SLI
Standard Lithium Ltd.
D 45/100 β€” β€” β€” -3.33% $358.0M /sli-vs-aspi β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001921865

In its most recent audited fiscal period (FY2025, filed 2025-12-31), ASP Isotopes Inc. (ASPI) reported GAAP revenue of $23.8M (+475.5% vs. FY2024 revenue of $4.1M , and +5407.5% cumulative change since FY2023) , GAAP net income of -$159.8M, operating cash flow of -$37.8M, and free cash flow of -$47.4M (-79.9% YoY). On the balance sheet, ASPI closed FY2025 with $498.0M in total assets against $1.5M in total debt (Altman Z-Score: 0.72, Piotroski F-Score: 4/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $23.8M -$159.8M -$37.8M -$47.4M $498.0M $1.5M
FY2024 (FY) 2024-12-31 $4.1M -$32.4M -$16.7M -$26.4M $94.3M $1.4M
FY2023 (FY) 2023-12-31 $433.0K -$16.3M -$5.4M -$5.4M β€” β€”

3. ASPI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ASPI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, ASP Isotopes Inc. (NASDAQ: ASPI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 21/100 at a spot price of $2.13 (+4.93% 1D, market cap $326.5M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, ASPI ranks #261 in composite RQD confidence.

How does ASPI compare to OEC and NL in the Materials sector?

Within the Materials sector (Major Chemicals), ASPI carries a Roarable E (21/100 RQD), trailing P/E of N/A, gross margin of 14.3%, and ROIC of -35.0%. By comparison, OEC (Orion S.A.) holds a D- grade (39/100 RQD, P/E N/A, ROIC 2.2%, cap $313.1M) and NL (NLI Holdings Inc.) posts a D grade (45/100 RQD, P/E N/A, ROIC 3.4%, cap $341.8M). Among the 5-stock peer group, ASPI leads on earnings multiple (N/A) while NL leads on capital efficiency (3.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ASPI?

Per ASPI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001921865), ASP Isotopes Inc. generated $23.8M in revenue (+475.5% YoY), -$159.8M in net income, and -$47.4M in free cash flow against $498.0M in total assets and $1.5M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ASPI trading relative to its 50-day, 200-day, and 52-week technical levels?

ASPI last traded at $2.13 (+4.93% on volume of 3,806,839 shares), positioning the stock -27.55% below its 50-day simple moving average ($2.94) and -55.90% below its 200-day simple moving average ($4.83). Across its 52-week range of $1.89 to $10.76, ASPI sits at the 2.7% percentile with a 14-day RSI of 39.4 (NEUTRAL RANGE) and an implied next-earnings move of Β±12.5% ($1.86 to $2.40).

ASPI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

Are ASPI insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies ASPI leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%